A new class of 3D printing resins for healthcare applications expands Henkel’s Loctite brand. The broad portfolio of high-performance photopolymers offers a range of biocompatibility standards from safe-to-touch parts to medical devices.
In addition to the established portfolio of Loctite 3D printing resins, the company innovates to deliver tailored formulations to fit the specific application requirements and market demands for optimised production.
Recently, the Henkel 3D printing facilities in Concord (laboratory) and Dixon (production) in California, have achieved the ISO 13485:2016 certification for medical applications. Henkel 3D printing resins are designed and manufactured in accordance with ISO 13485 quality management standards to ensure uniformity in design, development, production, and delivery of medical devices. In Henkel’s case specifically, it covers the design and manufacturing of biocompatible resins and other materials used to produce non-implantable medical devices.